Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05693636 |
Other study ID # |
2015/121 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
March 1, 2015 |
Est. completion date |
February 28, 2022 |
Study information
Verified date |
December 2022 |
Source |
Region Skane |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The wrist is often considered to be the fundament of the hand. Patients with a destroyed
wrist joint caused by osteoarthritis or rheumatoid arthritis may suffer from pain and
functional disabilities with impaired life quality.
The traditional surgical solution for advanced wrist arthritis is a total wrist fusion (TWF).
Although TWF creates a stable wrist with minimal pain, the prize is the joint motion. Total
wrist arthroplasty (TWA) is a motion-preserving alternative, but has failed to achieve the
widespread use of other joint replacement procedures. TWA is more costly and technically
demanding than TWF, and also associated with more complications. In addition, there is no
consensus regarding the functional benefit of a TWA compared to TWF since prospective,
comparative studies are missing.
Aim: The purpose of this prospective cohort study was to compare functional outcome and
activity limitations up to two years after surgery with TWA or TWF.
Description:
Patients with advanced wrist arthritis engaging both the midcarpal- and radiocarpal joints
may suffer from pain, decreased joint motion and reduced grip strength. The traditional
surgical solution with TWF creates a stable wrist with decreased pain, but the prize is the
loss of wrist motion. TWA may be a motion-preserving alternative, but is more technically
demanding and is associated with more complications compared to TWF. In addition, the
functional benefits of TWA over TWF are still unknown.
Aim: The purpose of this prospective cohort study was to compare functional outcome and
activity limitations up to two years after surgery with TWA or TWF.
Methods: In this single-center prospective, longitudinal cohort-study, all patients treated
with TWF or TWA due to end-stage wrist arthritis at one hand surgical department between
March 1, 2015, through February 28, 2020, were enrolled.The treatment method was decided by
the treating consultant in hand surgery, based on clinical evaluation of the patient and
radiographic appearance of the wrist, in combination with the patients' own requests and
prerequisites.
Assessments were performed at baseline, 3 months, 6 months, 12 months and 24 months after
surgery with patient-reported outcome measures, range-of-motion, grip strength and
radiographic evaluation.